Sparsentan for Focal Segmental Glomerulosclerosis May 19, 2025 • 12:00 a.m. Sparsentan for Focal Segmental GlomerulosclerosisMedpage Today, May 19, 2025 UTMB’s Dr. Shikha Wadhwani joined other experts to discuss the shift toward proteinuria-based endpoints that could finally bring a targeted drug to FSGS patients. Search Categories Awards & Accolades Education Faculty/Staff News Health Care In The News Innovations News Releases Top News UTMB Research Contact Media Team UTMB Experts
Sparsentan for Focal Segmental Glomerulosclerosis May 19, 2025 • 12:00 a.m. Sparsentan for Focal Segmental GlomerulosclerosisMedpage Today, May 19, 2025 UTMB’s Dr. Shikha Wadhwani joined other experts to discuss the shift toward proteinuria-based endpoints that could finally bring a targeted drug to FSGS patients.